Chilton Capital Management LLC Has $178,000 Stock Position in Intuitive Surgical, Inc. $ISRG

Chilton Capital Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 554.0% during the second quarter, Holdings Channel reports. The institutional investor owned 327 shares of the medical equipment provider’s stock after purchasing an additional 277 shares during the period. Chilton Capital Management LLC’s holdings in Intuitive Surgical were worth $178,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Resonant Capital Advisors LLC raised its stake in Intuitive Surgical by 16.9% during the 2nd quarter. Resonant Capital Advisors LLC now owns 1,816 shares of the medical equipment provider’s stock worth $987,000 after buying an additional 262 shares during the period. Wealthfront Advisers LLC raised its stake in Intuitive Surgical by 3.3% during the 2nd quarter. Wealthfront Advisers LLC now owns 46,167 shares of the medical equipment provider’s stock worth $25,088,000 after buying an additional 1,481 shares during the period. New Hampshire Trust raised its stake in Intuitive Surgical by 13.2% during the 2nd quarter. New Hampshire Trust now owns 796 shares of the medical equipment provider’s stock worth $433,000 after buying an additional 93 shares during the period. Oppenheimer Asset Management Inc. raised its stake in shares of Intuitive Surgical by 1.2% in the second quarter. Oppenheimer Asset Management Inc. now owns 53,308 shares of the medical equipment provider’s stock worth $28,968,000 after purchasing an additional 610 shares during the last quarter. Finally, Ingalls & Snyder LLC raised its stake in shares of Intuitive Surgical by 9.2% in the second quarter. Ingalls & Snyder LLC now owns 5,973 shares of the medical equipment provider’s stock worth $3,246,000 after purchasing an additional 503 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Sunday. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday. Wells Fargo & Company increased their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday, October 8th. Finally, Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG opened at $546.51 on Monday. The company has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61. The stock has a 50 day moving average of $458.09 and a 200 day moving average of $497.11. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same period last year, the business posted $1.84 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.